Foehr Matthew W - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	3	1	11	1	3	1	6	21	52	14
P	%wins				64	45	55	64	70	78	63

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/25/24 07:07	3/22/24	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P	1,168	5.19	0	225	8	2,909	D
12/13/23 15:25	12/12/23	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	CEO	P	1,010	5.05	0	200	8	2,645	D
11/13/23 08:00	11/10/23	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P	406	4.27	0	95	4	2,428	D
8/15/23 16:56	8/14/23	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P.d	247	5.48	0	45	2	2,333	D
6/12/23 16:47	6/9/23	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	CEO	P	520	4.52	0	115	5	2,574	D
5/15/23 16:02	5/12/23	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	CEO	P	1,496	3.40	0	440	22	2,438	D
12/14/22 17:00	12/12/22	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P	565	3.77	0	150	9	1,838	D
12/1/22 18:00	11/30/22	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P	1,016	3.39	0	300	21	1,705	D
11/9/22 20:30	11/9/22	OABI	Omniab, Inc.	DE	Health	Biolab	Commercial Physical & Biologi	Foehr Matthew W	CA	DO	P,CEO	P	276	2.76	0	100	8	1,405	D
5/13/22 19:05	5/13/22	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	P,COO	P	207	82.76	0	3	1	173	D
5/3/22 16:12	5/2/22	VKTX	Viking Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	111	2.47	0	45	68	111	D
6/10/21 16:57	6/10/21	VKTX	Viking Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	114	5.69	0	20	43	66	D
9/19/18 14:19	8/17/18	RTTR	Ritter Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P.a	40	2.04	0	20	564	23	D
8/20/18 17:19	8/17/18	RTTR	Ritter Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	40	2.04	0	20	56	55	D
5/18/17 15:39	5/18/17	RTTR	Ritter Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	11	0.6197	1	18	106	35	D		-64	-73	-82	-56	-39	-14	-5
11/15/16 16:34	11/15/16	VKTX	Viking Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	16	1.21	0	13	50	39	D		-76	-2	-9	-16	16	22	16	-1	-2	-10	32
4/13/16 18:17	4/13/16	VKTX	Viking Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P.d	25	1.24	1	20	320	26	D			-79	-53	-27	-18	-8	-30	-2	-3	0	4	3
1/11/16 16:40	1/8/16	RTTR	Ritter Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	21	1.64	0	13	325	17	D			-64	-36	-31	-7	-13	-5	3	-2	-19	-2	11	100
6/25/15 20:56	6/24/15	RTTR	Ritter Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	20	5.00	4	4	New	4	D									-2	-4	-13	-37	-57	-62
5/5/15 13:47	5/4/15	VKTX	Viking Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	D		P	50	8.00	1	6	New	6	D								6	0	-1	-17	-31	-41	-86
1/5/15 19:46	12/31/14	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P	2	45.23	13	0	0	55	D	159	4	-17	18	0	0	-1	3	-2	3	2	41	85	91
10/14/14 13:48	10/10/14	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P.d	4	44.91	23	0	0	55	D	158	-6	-26	-21	-16	-5	-2	2	2	12	27	16	90	95
7/1/14 12:16	6/30/14	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P	19	43.79	19	0	1	54	D	308	67	15	-7	-4	-10	-5	-1	2	-1	-18	-24	-16	62
1/2/14 16:48	12/31/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P	3	33.92	15	0	0	45	D	347	154	36	16	1	-2	-1	-3	1	7	20	28	23	3
7/1/13 15:27	6/28/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P	18	17.36	11	1	2	45	D	218	145	74	41	34	17	16	4	7	14	28	14	45	67
12/5/12 16:53	12/5/12	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Foehr Matthew W	CA	O	EVP,COO	P	7	17.99	3	0	1	38	D	120	59	51	8	20	5	-2	-6	0	8	7	25	70	198

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y